Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal ...

Eyenovia, Inc. (NASDAQ:EYEN – Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 138,200 shares, a drop of 41.4% from the ...

"Miosis" is a medical term that describes the constriction of the pupils. Learn its causes, symptoms, and how to treat it.

HC Wainwright restated their neutral rating on shares of Eyenovia (NASDAQ:EYEN – Free Report) in a report published on Friday morning,Benzinga reports. HC Wainwright currently has a $2.00 target price ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more information, ...

However, the incidence of blurred vision was higher with the gel (8.5% vs 3.5%), and the incidence of mydriasis was about the same (6.3% vs 6.8%). In addition, skin reactions from active therapy ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more ...

The company's current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more information, ...

The combination of cyclopentolate hydrochloride 0.2% and phenylephrine hydrochloride 1% (Cyclomydril ®) is desirable for mydriasis prior to examining premature infants because it delivers lower ...

Cataract surgery is performed more easily if mydriasis can be maintained until the intraocular lens has been inserted. Intraocular irrigation with adrenaline is thought to be of benefit in this ...